福瑞达 (600223)

Lushang Freda Pharmaceutical Co., Ltd.

ASH

Tags

DeepSeekSSE 380 IndexArtificial Intelligence (AI)MetaverseElderly Care ConceptSpin-off ListingsInnovative DrugsChemical Raw Materials and Products ManufacturingChemical IndustryMedical Aesthetics ConceptSynthetic BiologyInfant and Child ConceptPet EconomyTourism ConceptDaily ChemicalsProperty ManagementInternet Celebrity EconomyTencent ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 101656.88
  • Circulating A-Shares(W): 101656.88
  • Earnings Per Share(RMB): 0.1400
  • Net Assets Per Share(RMB): 4.1186
  • Operating Revenue(W RMB): 259681.29
  • Total Profit(W RMB): 20207.54
  • **Net Profit Attributable to Parent(W RMB) **: 14174.36
  • Net Profit Growth Rate(%): -17.19
  • Weighted Return on Equity(%): 3.4200
  • Operating Cash Flow Per Share(RMB): 0.0380
  • Undistributed Profit Per Share(RMB): 2.2543
  • Capital Reserve Per Share(RMB): 0.6040

2. Main Business

The main business covers:

  • Real estate development and management
  • Pharmaceutical and healthcare
  • Property management

3. Company Basic Information

  • Company Name: Lushang Furuida Pharmaceutical Co., Ltd.
  • Listing Date: 2000-01-13
  • Industry: Chemical raw materials and chemical products manufacturing
  • Address: No. 888 Xinluo Street, High-tech Zone, Jinan City, Shandong Province
  • Website: https://www.fruida.com.cn/
  • Company Profile: The company was originally named Shandong Zibo Wantongda Co., Ltd., with Wanjie Group Company as the main sponsor, jointly established by Zibo Fifth Cotton Mill, Shandong Zibo Wantongda Industrial Technology Research Institute, Zibo Bashan Dyestuff Chemical Plant, and Zibo Boshan Towel Factory through private placement. It was registered on April 21, 1993, with a total share capital of 135.988 million shares. In November 1995, the company absorbed and merged Boshan Thermal Power Plant under Wanjie Group, increasing the total share capital to 180 million shares. In 1998, the company absorbed and merged Shandong Zibo Wanjie Medical Co., Ltd., bringing the total share capital to 302.5 million shares. After issuing 93.5 million public shares on September 13, 1999, and allocating 16.5 million shares to securities investment funds, the total share capital reached 412.5 million shares. Its 93.5 million public shares were listed on the Shanghai Stock Exchange on January 13, 2000.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shandong Commercial Group Co., Ltd. Corporate Legal Person 52473.92 51.62
2 Lushang Group Co., Ltd. Corporate Legal Person 1721.00 1.69
3 National Social Security Fund 114 Portfolio Social Security Fund 1188.02 1.17
4 Shandong World Trade Center Corporate Legal Person 983.60 0.97
5 Southern China Securities 1000 ETF Fund 464.98 0.46

5. Concept Sectors

  • Baby & Child Concept
  • Elderly Care Concept
  • Artificial Intelligence
  • Tencent Concept
  • Internet Celebrity Economy
  • Medical Aesthetics Concept
  • Property Management
  • Metaverse
  • Tourism Concept
  • Innovative Drugs
  • Synthetic Biology
  • Pet Economy
  • DeepSeek

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information